SGLT 2 inhibitors
Clinical trials for SGLT 2 inhibitors explained in plain language.
Never miss a new study
Get alerted when new SGLT 2 inhibitors trials appear
Sign up with your email to follow new studies for SGLT 2 inhibitors, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Diabetes drug shows promise in fighting advanced cancers
Disease control Recruiting nowThis trial investigates whether canagliflozin, a diabetes drug, can be safely combined with the immunotherapy tislelizumab to treat advanced solid tumors. The study includes adults with unresectable, recurrent, or metastatic cancers who have not responded to standard treatments. …
Matched conditions: SGLT 2 INHIBITORS
Phase 1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Diabetes drug may fight inflammation after stent procedure
Disease control Recruiting nowThis study tests whether empagliflozin, a diabetes drug, can reduce inflammation after a heart stent procedure. 100 patients with stable coronary artery disease will take either empagliflozin or a placebo for three days before their scheduled stent placement. Researchers will mea…
Matched conditions: SGLT 2 INHIBITORS
Phase 4 • Sponsor: Hotel Dieu de France Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC